Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML

NCT06741722 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

AML
Relapsed Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia

Interventions

DRUG: Decitabine, Azacitidine, Mitoxantrone liposome, Cytarabine, G-CSF

Sponsor

Beijing 302 Hospital